Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2018

Conditions
Carcinoma of the Oesophagus
Interventions
DRUG

Olaparib

25mg tablets, oral. Commenced 3 days prior to radiotherapy and continuing until the last day of radiotherapy (36 days in total).

RADIATION

Radical external beam radiotherapy, 50Gy in 25 fractions

Radiotherapy to the oesophageal carcinoma. For patients receiving olaparib this is delivered as 50Gy in 25 daily fractions for 5 weeks (Monday-Friday only). For patients in the comparator arm (RT only) other total doses/ fractionation are permitted, according to local policy/ best standard care.

Trial Locations (2)

M20 4BX

NOT_YET_RECRUITING

The Christie NHS Foundation Trust, Manchester

SO16 6YD

RECRUITING

Southampton General Hospital, Southampton

Sponsors
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

The Christie NHS Foundation Trust

OTHER